IRADIMED CORP Annual Selling and Marketing Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Iradimed Corp quarterly/annual Selling and Marketing Expense history and growth rate from 2013 to 2023.
  • Iradimed Corp Selling and Marketing Expense for the quarter ending June 30, 2024 was $3.48M, a 17.9% increase year-over-year.
  • Iradimed Corp Selling and Marketing Expense for the twelve months ending June 30, 2024 was $12.7M, a 21.6% increase year-over-year.
  • Iradimed Corp annual Selling and Marketing Expense for 2023 was $12.1M, a 4.24% decline from 2022.
  • Iradimed Corp annual Selling and Marketing Expense for 2022 was $12.7M, a 20.1% increase from 2021.
  • Iradimed Corp annual Selling and Marketing Expense for 2021 was $10.6M, a 3.91% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.1M -$538K -4.24% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 $12.7M +$2.12M +20.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 $10.6M +$397K +3.91% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $10.2M +$989K +10.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-04
2019 $9.17M +$2.17M +31.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-04
2018 $7M +$1.49M +27.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-05
2017 $5.5M +$225K +4.25% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-06
2016 $5.28M +$572K +12.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $4.71M +$1.41M +42.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $3.3M +$1M +43.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 $2.3M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.